These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29288623)

  • 1. Meeting report: FDA public meeting on patient-focused drug development and medication adherence in solid organ transplant patients.
    Ettenger R; Albrecht R; Alloway R; Belen O; Cavaillé-Coll MW; Chisholm-Burns MA; Dew MA; Fitzsimmons WE; Nickerson P; Thompson G; Vaidya P
    Am J Transplant; 2018 Mar; 18(3):564-573. PubMed ID: 29288623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients.
    Sankaranarayanan J; Collier D; Furasek A; Reardon T; Smith LM; McCartan M; Langnas AN
    Res Social Adm Pharm; 2012; 8(3):228-39. PubMed ID: 21856247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting report: Consensus recommendations for a research agenda to address immunosuppressant nonadherence in organ transplantation.
    Maldonado AQ; West-Thielke P; Dew MA; Peipert JD; Heldenbrand S; Kaiser TE; Chisholm-Burns M; Potter LM;
    Clin Transplant; 2018 Sep; 32(9):e13362. PubMed ID: 30053319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation.
    Karpen SR; Klein A; Alloway RR; Albrecht R; Belen O; Campbell M; Kluetz P; Minasian LM; Mitchell SA; O'Doherty I; Papadopoulos E; Sapir-Pichhadze R; Spear N; van Gelder T; Velidedeoglu E; Page CA; Everly MJ
    Transplantation; 2021 May; 105(5):941-944. PubMed ID: 33901129
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions.
    Kung M; Koschwanez HE; Painter L; Honeyman V; Broadbent E
    Transplantation; 2012 May; 93(9):958-63. PubMed ID: 22343337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public-private partnerships in transplant drug development.
    Albrecht R; Papadopoulos EJ; Campbell M; Daniels S; Kluetz PG; Parekh A; Wang Y
    Am J Transplant; 2020 Feb; 20(2):377-381. PubMed ID: 31553120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward.
    Stegall MD; Morris RE; Alloway RR; Mannon RB
    Am J Transplant; 2016 Apr; 16(4):1094-101. PubMed ID: 26730885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal stability of medication adherence among adolescent solid organ transplant recipients.
    Loiselle KA; Gutierrez-Colina AM; Eaton CK; Simons LE; Devine KA; Mee LL; Blount RL
    Pediatr Transplant; 2015 Jun; 19(4):428-35. PubMed ID: 25879392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing medication adherence in solid-organ transplant recipients.
    Su GC; Greanya ED; Partovi N; Yoshida EM; Shapiro RJ; Levy RD
    Exp Clin Transplant; 2013 Dec; 11(6):475-81. PubMed ID: 24344939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fourth International Workshop on Clinical Transplant Tolerance.
    Issa F; Strober S; Leventhal JR; Kawai T; Kaufman DB; Levitsky J; Sykes M; Mas V; Wood KJ; Bridges N; Welniak LA; Chandran S; Madsen JC; Nickerson P; Demetris AJ; Lakkis FG; Thomson AW
    Am J Transplant; 2021 Jan; 21(1):21-31. PubMed ID: 32529725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens.
    Hathaway D; Winsett R; Prendergast M; Subaiya I
    Clin Transplant; 2003 Jun; 17(3):183-94. PubMed ID: 12780666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adherence to Immunosuppressive Medication Following Organ Transplantation].
    Nöhre M; Erim Y; Vitinius F; Klewitz F; Schiffer M; de Zwaan M
    Psychother Psychosom Med Psychol; 2018 May; 68(5):185-194. PubMed ID: 29439280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of immunosuppressant adherence interventions in transplant recipients: Decoding the streetlight effect.
    Duncan S; Annunziato RA; Dunphy C; LaPointe Rudow D; Shneider BL; Shemesh E
    Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29218760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression in the pediatric transplant recipient.
    Blondet NM; Healey PJ; Hsu E
    Semin Pediatr Surg; 2017 Aug; 26(4):193-198. PubMed ID: 28964473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression following organ transplantation. Part 1: mechanisms and immunosuppressive agents.
    Cajanding R
    Br J Nurs; 2018 Sep; 27(16):920-927. PubMed ID: 30187798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression in uterus transplantation: from transplant to delivery.
    D'Amico G; Del Prete L; Eghtesad B; Hashimoto K; Miller C; Tzakis A; Quintini C; Falcone T
    Expert Opin Pharmacother; 2023 Jan; 24(1):29-35. PubMed ID: 35723045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients.
    Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA
    Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive Medication Adherence in Liver Transplant Recipients.
    Promraj R; Dumronggittigule W; Sirivatanauksorn Y; Ruenrom A; Tovikkai C; Limsrichamrern S; Kositamongkol P; Mahawithitwong P; Asavakarn S
    Transplant Proc; 2016 May; 48(4):1198-201. PubMed ID: 27320586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotherapeutics in transplantation: How do we get to clinical implementation?
    Plumblee L; Atkinson C; Jaishankar D; Scott E; Tietjen GT; Nadig SN
    Am J Transplant; 2022 May; 22(5):1293-1298. PubMed ID: 35224837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report.
    Mannon RB; Morris RE; Abecassis M; Axelrod D; Bala S; Friedman GS; Heeger PS; Lentine KL; Loupy A; Murphy B; Nickerson P; Sarwal M; O'Doherty I; Spear N; Karpen SR
    Am J Transplant; 2020 Jun; 20(6):1495-1502. PubMed ID: 32090461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.